References
- Reilly, J.G., McTavish, S.F.B. and Young, A.H. (1997) "Rapid depletion of plasma tryptophan: a review of studies and experimental methodology", J. Psychopharmacol. 11, 381–392.
- Cook, E.H., Anderson, G.M., Heninger, G.R., Fletcher, K.E., Freedman, DX. and Leventhal, B.L. (1992) "Tryptophan loading in hyperserotonaemic and normoserotonaemic adults", Biol. Psychiat. 31, 525–528.
- Huether, G., Hajak, G., Reimer, A., Poeggeler, B., Blomer, M., Rodenbecj, A. and Ruther, E. (1992) "The metabolic fate of infused L-tryptophan in men: possible clinical implications of the accumulation of circulating tryptophan and tryptophan metabolites", Psychopharmacology 109, 422–432.
- Luciana, M., Burg-un, ED., Berman, M. and Hanson, K.L. (2001) "Effects of tryptophan loading on verbal, spatial and effective working memory functions in healthy adults", J. Psychopharmacol. 15, 219–230.
- Stone, T.W. and Perkins, M.N. (1981) "Quinolinic acid: a potent endogenous excitant at amino acid receptors in the CNS", Fur. J. Pharmacol. 72, 411–412.
- Perkins, M.N. and Stone, T.W. (1982) "An iontophoretic investigation of the action of convulsant kynurenines and their interaction with the endogenous excitant quinolinic acid", Brain Res. 247, 184–187.
- Behan, W.M.H., McDonald, M., Darlington, L.G. and Stone, T.W. (1999) "Oxidative stress as a mechanism for quinolinic acid—induced hippocampal damage: protection by mela-tonin and deprenyl", Br. J. Pharmacol. 128, 1754–1760.
- Stone, T.W. (2001) "Kynurenines in the CNS: from endo-genous obscurity to therapeutic importance", Prog. Neurobiol. 64, 185–218.
- Stone, T.W. and Darlington, L.G. (2002) "Endogenous kynurenines as targets for drug discovery and development", Nature Revs. Drug Discovery 1, 609–620.
- Esterbauer, H., Schaur, R.J. and Zollner, H. (1991) "Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes", Free Radic. Biol. Med. 11, 81–128.
- Stone, T.W., Mackay, G.M., Forrest, C.M., Clark, C.J. and Darlington, L.G. (2003) "Tryptophan metabolites and brain disorders", Clin. Chem. Lab. Med. 41, 852–859.
- Herve, C., Beyne, P., Jamault, H. and Delacoux, E. (1996) "Determination of tryptophan and its kynurenine pathway metabolites in human serum by high-performance liquid chromatography with simultaneous ultraviolet and fluori-metric detection", J. Chromatogr. B 675, 157–161.
- Gerard-Monnier, D., Erdelmeier, I., Regnard, K., Moze-Henry, N., Yadan, J.C. and Chaudiere, J. (1998) "Reactions of 1-methyl-2-phenylindole with malondialdehyde and 4-hydroxyalkenals. Analytical applications to a colon-metric assay of lipid permddation", Chem. Res. Toxicol. 11, 1176–1183.
- Erdelmeier, I., Gerard-Monnier, D., Yadan, J.C. and Chaudiere, J. (1998) "TI Reactions of N-methy1-2-phenylindole with malondi-aldehyde and 4-hydroxyalkenals. Mechanistic aspects of the colorimetric assay of lipid permddation", Chem. Res. Toxicol. 11, 1184–1194.
- Eastman, C.L. and Guilarte, T.R. (1990) "The role of hydrogen peroxide in the in vitro cytotoxicity of 3-hydroxykynurenine", Neurochem. Res. 15, 1101–1107.
- Okuda, S., Nishiyama, N., Saito, H. and Katsuki, H. (1996) "Hydrogen peroxide-mediated neuronal cell death induced by an endogenous neurotoxin, 3-hydroxykynurenine", Proc. Nat. Acad. Sci. USA 93, 12553–12558.
- Murm, D.H., Zhou, M., Attwood, J.T., Bondarev, I., Conway, S.J., Marshall, B., Brown, C. and Mellor, A.L. (1998) "Prevention of allogeneic fetal rejection by tryptophan catabolism", Science 281, 1191–1193.
- Foster, G.D., Wyatt, H.R., Hill, JO., McGuckin, B.G., Brill, C., Mohammed, B.S., Szapary, P.O., Rader, D.J., Edman, J.S. and Klein, S. (2003) "A randomized trial of a low-carbohydrate diet for obesity", N. Engl. J. Med. 348, 2082–2090.